Resultados de la búsqueda
Latina J, Fernandez-Jimenez R, Bansilal S, Sartori S, Vedanthan R, Lewis M, Kofler C, Hunn M, Martin F, Bagiella E, Farkouh M, Fuster V Grenada Heart Project-Community Health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): A randomized control peer group-based lifestyle intervention Am Heart J (2020) 220:20-8
Link to the full text in Repisalud
Link to the full text in Repisalud
Romaguera R, Salinas P, Brugaletta S, Gomez-Lara J, Diaz JF, Romero MA, Garcia-Blas S, Ocaranza R, Borde P, Jimenez Kockar M, Millan Segovia R, Iniguez A, Alameda M, Trillo R, Lee DH, Martin P, Lopez-Benito M, Frutos A, Moreu J, Hernandez-Hernandez F, Garcia Del Blanco B, Roura G, Rossello X, Pocock SJ, Fernandez-Ortiz A, Sabate M, Gomez-Hospital JA Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design Am Heart J (2020) 222:174-182
Rodriguez-Leor O, Cid Alvarez AB, de Prado AP, Rossello X, Ojeda S, Serrador A, Lopez-Palop R, Martin-Moreiras J, Rumoroso JR, Cequier A, Ibanez B, Cruz-Gonzalez I, Romaguera R, Moreno R In-hospital outcomes of patients with ST-segment elevation myocardial infarction and COVID-19 EuroIntervention (2020) Nov 18 [Epub ahead of print]
Izidoro MA, Cecconi A, Panadero MI, Mateo J, Godzien J, Vilchez JP, Lopez-Gonzalvez A, Ruiz-Cabello J, Ibanez B, Barbas C, Ruperez FJ Plasma Metabolic Signature of Atherosclerosis Progression and Colchicine Treatment in Rabbits Sci Rep (2020) 10:7072
Link to the full text in Repisalud
Link to the full text in Repisalud
Roche-Molina M, Hardwick B, Sanchez-Ramos C, Sanz-Rosa D, Gewert D, Cruz FM, Gonzalez-Guerra A, Andres V, Palma JA, Ibanez B, McKenzie G, Bernal JA The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Kruppel-like factor 2 activation to reduce atherogenesis Sci Rep (2020) 10:11636
Link to the full text in Repisalud
Link to the full text in Repisalud
Asensio Lopez MDC, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes Genis A, Pascual Figal DA Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status Sci Rep (2020) 10:13553
Hoedemaker NP, Roolvink V, de Winter RJ, van Royen N, Fuster V, Garcia-Ruiz JM, Er F, Gassanov N, Hanada K, Okumura K, Ibanez B, van 't Hof AW, Damman P. Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials. Eur Heart J Acute Cardiovasc Care (2020) 9:469-477
Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E, Cobain M, Piepoli MF, Visseren FL, Dendale P. Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur Heart J Acute Cardiovasc Care (2020) 9:522-532
Zeymer U, Bueno H, Granger CB, Hochman J, Huber K, Lettino M, Price S, Schiele F, Tubaro M, Vranckx P, Zahger D, Thiele H Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology Eur Heart J Acute Cardiovasc Care (2020) 9:183-197
Rossello X, Medina J, Pocock S, Van de Werf F, Chin CT, Danchin N, Lee SW, Huo Y, Bueno H Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking Eur Heart J Acute Cardiovasc Care (2020) 9:911-922